101 related articles for article (PubMed ID: 25163778)
21. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.
Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT
Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098
[TBL] [Abstract][Full Text] [Related]
22. Decline in hepatitis B infection observed after 11 years of regional vaccination among Danish drug users.
Mössner BK; Skamling M; Jørgensen TR; Georgsen J; Pedersen C; Christensen PB
J Med Virol; 2010 Oct; 82(10):1635-9. PubMed ID: 20827758
[TBL] [Abstract][Full Text] [Related]
23. Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection.
Thomas DL; Factor SH; Kelen GD; Washington AS; Taylor E; Quinn TC
Arch Intern Med; 1993 Jul; 153(14):1705-12. PubMed ID: 8333808
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B seroprevalence in children and women and the impact of the hepatitis B vaccination program in the Black Sea Region of Turkey.
Karatekin G; Kilinç M; Gulcan Öksuz B; Iğde M
J Infect Dev Ctries; 2013 Dec; 7(12):960-5. PubMed ID: 24334943
[TBL] [Abstract][Full Text] [Related]
25. Trends in the seroprevalence of hepatitis B surface antigen in the South Korean population.
Park SH
Int J Infect Dis; 2012 Sep; 16(9):e669-72. PubMed ID: 22738792
[TBL] [Abstract][Full Text] [Related]
26. Cross-sectional, anonymous screening for asymptomatic HCV infection, immunity to HBV, and occult HBV infection among health care workers in Warsaw, Poland.
Slusarczyk J; Małkowski P; Bobilewicz D; Juszczyk G
Przegl Epidemiol; 2012; 66(3):445-51. PubMed ID: 23230715
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B and C: neglected diseases among health care workers in Cameroon.
Fritzsche C; Becker F; Hemmer CJ; Riebold D; Klammt S; Hufert F; Akam W; Kinge TN; Reisinger EC
Trans R Soc Trop Med Hyg; 2013 Mar; 107(3):158-64. PubMed ID: 23303802
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus and hepatitis C virus seroprevalence in rural areas of the southwestern region of Turkey.
Akcam FZ; Uskun E; Avsar K; Songur Y
Int J Infect Dis; 2009 Mar; 13(2):274-84. PubMed ID: 18945630
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of hepatitis B surface antigen and hepatitis C virus antibodies among blood donors in Alexandria, Egypt.
Wasfi OA; Sadek NA
East Mediterr Health J; 2011 Mar; 17(3):238-42. PubMed ID: 21735965
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of viral hepatitis B and C in riverside communities of the Tucuruí Dam, Pará, Brazil.
de Almeida MK; Dos Santos KN; Fecury AA; de Oliveira CS; Freitas AS; Quaresma JA; Fuzii HT; Martins LC
J Med Virol; 2012 Dec; 84(12):1907-12. PubMed ID: 23080495
[TBL] [Abstract][Full Text] [Related]
31. Dynamics of viral hepatitis B epidemiological process in Plovdiv region.
Kevorkyan-Sariyan AK
Folia Med (Plovdiv); 2013; 55(2):97-8. PubMed ID: 24191410
[TBL] [Abstract][Full Text] [Related]
32. Seroprevalence of hepatitis B and C viruses among HIV-infected pregnant women in Uganda and Rwanda.
Pirillo MF; Bassani L; Germinario EA; Mancini MG; Vyankandondera J; Okong P; Vella S; Giuliano M
J Med Virol; 2007 Dec; 79(12):1797-801. PubMed ID: 17935164
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of hepatitis B and C infections among young adult males in Pakistan.
Butt T; Amin MS
East Mediterr Health J; 2008; 14(4):791-7. PubMed ID: 19166161
[TBL] [Abstract][Full Text] [Related]
35. [Markers of hepatitis B, C and HIV among orthopedic patients and staff at a Polish university hospital].
Gańczak M; Bohatyrewicz A; Szych Z; Białecki P
Chir Narzadow Ruchu Ortop Pol; 2008; 73(2):83-8. PubMed ID: 18846999
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and molecular analysis of hepatitis A, B and C in a semi-urban and rural area of Crete.
Drositis I; Bertsias A; Lionis C; Kouroumalis E
Eur J Intern Med; 2013 Dec; 24(8):839-45. PubMed ID: 23988264
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence and risk factors for hepatitis B and C virus infection in Damietta Governorate, Egypt.
Edris A; Nour MO; Zedan OO; Mansour AE; Ghandour AA; Omran T
East Mediterr Health J; 2014 Oct; 20(10):605-13. PubMed ID: 25356691
[TBL] [Abstract][Full Text] [Related]
38. [Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China].
Zhang L; Yan BY; Li MS; Song LZ; Lü JJ; Xu Q; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):933-9. PubMed ID: 24378135
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of the nationwide hepatitis B infant vaccination program in Taiwan.
Chen SM; Kung CM; Yang WJ; Wang HL
J Clin Virol; 2011 Sep; 52(1):11-6. PubMed ID: 21767983
[TBL] [Abstract][Full Text] [Related]
40. [Shifting in seroprevalence of HBsAg and anti-HCV during recent 10 years in adults resident in Daegu and Gyeongbuk province].
Lee KI; Park KS; Seo HJ; Kim TY; Kim ES; Jang BK; Chung WJ; Cho KB; Hwang JS
Korean J Gastroenterol; 2011 Dec; 58(2):82-7. PubMed ID: 21873822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
